Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Neoplasms 9Hypothyroidism 7Thyroid Diseases 1Thyroid Cancer, Papillary 1Sarcoma, Alveolar Soft Part 1Recurrence 1Postoperative Complications 1Polycystic Ovary Syndrome 1Neoplasms 1Laryngeal Neoplasms 1Infertility, Female 1Head and Neck Neoplasms 1Goiter 1Fatigue 1Depression 1Brain Neoplasms 1Anxiety Disorders 1Advanced Differentiated Thyroid Gland Carcinoma 1

Interventions

Metformin 152Clomiphene 52Letrozole 41Inositol 34Folic Acid 18Progesterone 17Exercise 17Ethinyl Estradiol 13Estradiol 13Chorionic Gonadotropin 13Caloric Restriction 13drospirenone and ethinyl estradiol combination 12Contraceptives, Oral 12cetrorelix 11Pioglitazone 10High-Intensity Interval Training 10Cholecalciferol 10Triptorelin Pamoate 9Tablets 9Spironolactone 9Menotropins 8Diet 8Vitamin D 7Thioctic Acid 7Surveys and Questionnaires 7Liraglutide 7Gonadotropins 7Acupuncture Therapy 7follitropin alfa 6drospirenone 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Polycystic Ovary Syndrome × Thyroxine × Clear all
NCT06041204 2025-09-03

Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism

Al-Azhar University

Phase NA Recruiting
200 enrolled

Infertility, Female, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡